KR102483912B1 - Method for producing soft capsule type functional health food - Google Patents

Method for producing soft capsule type functional health food Download PDF

Info

Publication number
KR102483912B1
KR102483912B1 KR1020200136941A KR20200136941A KR102483912B1 KR 102483912 B1 KR102483912 B1 KR 102483912B1 KR 1020200136941 A KR1020200136941 A KR 1020200136941A KR 20200136941 A KR20200136941 A KR 20200136941A KR 102483912 B1 KR102483912 B1 KR 102483912B1
Authority
KR
South Korea
Prior art keywords
soft capsule
coating
health functional
functional food
liquid
Prior art date
Application number
KR1020200136941A
Other languages
Korean (ko)
Other versions
KR20210123989A (en
Inventor
김한철
Original Assignee
주식회사 코스팜
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코스팜 filed Critical 주식회사 코스팜
Priority to KR1020200136941A priority Critical patent/KR102483912B1/en
Publication of KR20210123989A publication Critical patent/KR20210123989A/en
Application granted granted Critical
Publication of KR102483912B1 publication Critical patent/KR102483912B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10Coating with edible coatings, e.g. with oils or fats
    • A23P20/11Coating with compositions containing a majority of oils, fats, mono/diglycerides, fatty acids, mineral oils, waxes or paraffins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10Coating with edible coatings, e.g. with oils or fats
    • A23P20/15Apparatus or processes for coating with liquid or semi-liquid products
    • A23P20/18Apparatus or processes for coating with liquid or semi-liquid products by spray-coating, fluidised-bed coating or coating by casting

Abstract

프로바이오틱스 균주를 함유한 연질캡슐로서 소장에서 함유성분을 노출시키는 건강기능식품의 제조방법이 개시된다. 연질캡슐형 건강기능식품의 제조방법은, 측량된 건강기능식품의 원료를 상대습도 65% 이하, 온도 20℃ 내지 24℃의 분위기에서 30분 내지 50분간 배합하는 단계, 배합한 원료가 충진된 연질캡슐을 생성하는 단계, 및 연질캡슐 상에 액상의 코팅 물질을 분무하여 코팅층을 형성하는 단계를 포함하며, 코팅 물질은 지방, 지방산, 왁스, 쉘락, 초산프탈산셀룰로오스, 프탈산히드록시메틸셀룰로오스(hydroxypropyl methylcellulose, HPMC)로 이루어진 그룹에서 선택되는 어느 하나 이상을 포함하고, 원료는 락토바실러스(lactobacillus), 락토코커스, 엔테로코커스(enterococcus), 스트렙토코커스(streptococcus) 및 비피도박테리움(bifidobacterium)로 이루어진 그룹에서 선택되는 어느 하나 이상의 프로바이오틱스 균주를 포함한다.Disclosed is a method for producing a health functional food in which the ingredients are exposed in the small intestine as a soft capsule containing a probiotics strain. A method for manufacturing a soft capsule-type health functional food includes mixing raw materials of the measured health functional food in an atmosphere with a relative humidity of 65% or less and a temperature of 20 ° C to 24 ° C for 30 to 50 minutes; Forming a coating layer by forming a capsule, and spraying a liquid coating material on the soft capsule, wherein the coating material is fat, fatty acid, wax, shellac, cellulose phthalate, hydroxypropyl methylcellulose phthalate , HPMC), and the raw material is from the group consisting of lactobacillus, lactococcus, enterococcus, streptococcus and bifidobacterium. It includes any one or more probiotics strains selected.

Description

연질캡슐형 건강기능식품의 제조방법{METHOD FOR PRODUCING SOFT CAPSULE TYPE FUNCTIONAL HEALTH FOOD}Manufacturing method of soft capsule type health functional food {METHOD FOR PRODUCING SOFT CAPSULE TYPE FUNCTIONAL HEALTH FOOD}

본 발명은 건강기능식품에 관한 것으로, 보다 상세하게는 프로바이오틱스 균주를 함유한 연질캡슐로서 소장에서 함유성분을 노출시키는 건강기능식품의 제조방법에 관한 것이다.The present invention relates to health functional food, and more particularly, to a method for manufacturing a health functional food as a soft capsule containing probiotics strains and exposing the constituents in the small intestine.

건강기능식품이라 함은 인체에 유용한 기능을 가진 원료나 성분을 사용하여 정제(tablet), 캡슐(capsule), 환(pill), 과립(granule), 분말(powder), 액상(lipid), 편상(flake), 페이스트상(paste), 시럽(syrup), 겔(gel), 젤리(jelly), 바(bar), 필름(film) 등의 형태로 제조(가공을 포함한다)한 식품을 말한다. 여기서 원료는 건강기능식품 제조에 사용되는 물질로 최종 제품 내에 들어 있는 것을 말하고, 성분은 분리된 단일 물질 또는 원료에 함유되어 있는 단일 물질로 최종 제품내에 들어 있는 것을 말한다.Health functional food refers to a tablet, capsule, pill, granule, powder, liquid, or flake form (tablet, capsule, pill, powder, etc.) It refers to food manufactured (including processing) in the form of flake, paste, syrup, gel, jelly, bar, film, etc. Here, raw materials refer to substances used in the manufacture of health functional foods and are included in the final product, and ingredients refer to separate single substances or substances contained in raw materials and contained in the final product.

건강기능식품은 영양소 기능, 생리활성 기능, 및 질병발생위험감소 기능의 기능성 등급을 가진다. 영양소 기능은 비타민 C 등을 사용하여 인체의 성장 증진 및 정상적인 기능에 대한 영양소의 생리적인 작용과 관련된 것을 지칭하고, 생리활성 기능은 루테인이나 코엔자임Q10 등을 사용하여 인체의 정상기능이나 생물학적 활동에 특별한 효과가 있어 건강상의 기여나 기능향상 또는 건강유지, 개선을 나타내는 기능을 말하며, 질병발생위험감소 기능은 칼슘이나 비타민 D 등을 사용하여 질병의 발생 또는 건강상태의 위험감소와 관련된 기능을 말한다.Health functional foods have functional levels of nutrient function, physiological activity function, and disease risk reduction function. Nutrient function refers to the physiological action of nutrients for the growth promotion and normal function of the human body using vitamin C, etc., and physiological activity function refers to a specific function for the normal function or biological activity of the human body using lutein or coenzyme Q10. It refers to a function that shows contribution to health, function improvement, health maintenance, or improvement, and disease risk reduction function refers to a function related to disease occurrence or health condition risk reduction by using calcium or vitamin D.

대표적인 건강기능식품 중 하나인 프로바이오틱스는 장관(腸管)에서 서식하며 건강에 도움을 주는 유익균들을 총칭하며 대표적으로 요거트 발효에 사용되는 유산균(lactic acid bacteria)을 말한다. 이들은 구강 충치균 저해, 체내 면역체계 조절(항염증반응 촉진, 알러지성 증상 경감 등), 과민성대장증후군 완화, 정장작용 등 다양한 생리활성 효과를 나타내는 것으로 알려져 있다.Probiotics, one of the representative health functional foods, is a general term for beneficial bacteria that live in the intestinal tract and help health, and refers to lactic acid bacteria typically used in yogurt fermentation. They are known to exhibit various physiological activities such as inhibition of oral cavity bacteria, regulation of the body's immune system (promoting anti-inflammatory response, reduction of allergic symptoms, etc.), alleviation of irritable bowel syndrome, and intestinal function.

최근 프로바이오틱스를 분말화하여 건강기능식품으로 제조하려고 하는 연구개발이 많이 진행되고 있다. 프로바이오틱스 분말은 빵, 과자, 초콜릿, 크림, 소스, 껌, 음료 등 다양한 식품에 적용이 용이하여 식품의 건강기능성을 증진시킬 수 있는 소재로 유용하며, 액상에 비하여 보관 및 취급이 용이하고 그 자체로 상품화가 가능하다는 장점을 갖고 있다. 따라서 분말 제조공정의 효율성을 높이고, 분말의 특성을 조절하고, 제조 및 저장 중이나 섭취 시에 프로바이오틱스의 생존율과 효능을 향상시키기 위한 다양한 연구개발이 진행되고 있다.Recently, a lot of research and development is being conducted to powder probiotics and prepare them as health functional foods. Probiotics powder is useful as a material that can improve the health function of food as it can be easily applied to various foods such as bread, confectionery, chocolate, cream, sauce, gum, and beverages, and is easier to store and handle than liquid. It has the advantage of commercialization. Therefore, various researches and developments are being conducted to increase the efficiency of the powder manufacturing process, control the characteristics of the powder, and improve the survival rate and efficacy of probiotics during manufacturing and storage or ingestion.

등록특허 제10-1973333호(2019.04.29)Registered Patent No. 10-1973333 (2019.04.29)

본 발명은 전술한 종래 기술의 문제점을 개선하기 위해 도출된 것으로 본 발명의 목적은 유산균을 함유하고 위(stomach)에서는 제형이 그대로 유지되고 소장에서 함유성분을 노출시키는 연질캡슐형 건강기능식품의 제조방법을 제공하는 데 있다.The present invention was derived to improve the problems of the prior art, and an object of the present invention is to manufacture a soft capsule-type health functional food that contains lactic acid bacteria, maintains the formulation in the stomach, and exposes the contained ingredients in the small intestine. to provide a way

상기 기술적 과제를 해결하기 위한 본 발명의 일 측면에 따른 연질캡슐형 건강기능식품의 제조방법은, 측량된 건강기능식품의 원료를 상대습도 65% 이하, 온도 20℃ 내지 24℃의 분위기에서 30분 내지 50분간 배합하는 단계, 배합한 원료가 충진된 연질캡슐을 생성하는 단계, 및 연질캡슐 상에 액상의 코팅 물질을 온도 55℃ 내지 65℃에서 1시간 내지 2시간 동안 분무하여 연질캡슐 용량 500㎎ 당 2㎎ 용량의 코팅층을 형성하는 단계를 포함한다. 코팅 물질은 지방, 지방산, 왁스, 쉘락, 초산프탈산셀룰로오스, 프탈산히드록시메틸셀룰로오스(hydroxypropyl methylcellulose, HPMC)로 이루어진 그룹에서 선택되는 어느 하나 이상을 포함한다.In order to solve the above technical problem, the method for manufacturing a soft capsule-type health functional food according to an aspect of the present invention, the raw material of the measured health functional food is heated for 30 minutes in an atmosphere with a relative humidity of 65% or less and a temperature of 20 ° C to 24 ° C. mixing for 50 minutes, creating soft capsules filled with the blended raw materials, and spraying a liquid coating material on the soft capsules at a temperature of 55°C to 65°C for 1 hour to 2 hours to obtain a soft capsule capacity of 500 mg. Forming a coating layer of 2 mg per dose. The coating material includes at least one selected from the group consisting of fat, fatty acid, wax, shellac, cellulose phthalate acetate, and hydroxymethyl cellulose phthalate (HPMC).

일실시예에서, 상기 건강기능식품의 제조방법은, 상기 코팅하는 단계에서 HPMC 6~10중량%, 코팅액 분사량 7.5~15.0g/min 및 흡기 온도 28℃ 내지 40℃의 코팅 조건에서 코팅 물질을 함유한 코팅액을 분무하여 연질캡슐의 표면에 부착시키면서 분사되는 즉시 연질캡슐 표면에 부착되어 가루형태로 건조되도록 에어 스프레이를 사용하는 공정에서, 코팅액이 분사될 때까지 그리고 연질캡슐 표면에 부착될 때까지 연질캡슐 표면에 균일한 코팅액이 균일하게 붙어 건조되도록 코팅 환경을 유지하는 것이 바람직하다.In one embodiment, the method for producing the health functional food contains a coating material under the coating conditions of 6 to 10% by weight of HPMC, 7.5 to 15.0 g / min of coating liquid injection, and 28 ° C to 40 ° C of intake air temperature in the coating step. In the process of using air spray so that a coating liquid is sprayed and adhered to the surface of the soft capsule and dried in powder form as soon as it is sprayed, the coating liquid is soft until it is sprayed and adhered to the soft capsule surface. It is preferable to maintain a coating environment so that a uniform coating solution is uniformly attached to the surface of the capsule and dried.

일실시예에서, 상기 원료는 락토바실러스(lactobacillus), 락토코커스, 엔테로코커스(enterococcus), 스트렙토코커스(streptococcus) 및 비피도박테리움(bifidobacterium)로 이루어진 그룹에서 선택되는 어느 하나 이상의 프로바이오틱스 균주를 포함한다.In one embodiment, the raw material includes one or more probiotic strains selected from the group consisting of lactobacillus, lactococcus, enterococcus, streptococcus and bifidobacterium. .

전술한 연질캡슐형 건강기능식품의 제조방법을 사용하는 경우에는, 락토바실러스(lactobacillus), 락토코커스(lactococcus), 엔테로코커스(enterococcus), 스트렙토코커스(streptococcus) 및 비피도박테리움(bifidobacterium)으로 이루어진 그룹에서 선택되는 어느 하나 이상의 프로바이오틱스 균주를 함유한 정제 또는 과립으로서 위(stomach)에는 그대로 남아있고 소장에서 함유성분을 노출시키는 건강기능식품 연질캡슐을 제공할 수 있다.In the case of using the above-mentioned manufacturing method of the soft capsule type health functional food, lactobacillus, lactococcus, enterococcus, streptococcus and bifidobacterium consisting of As a tablet or granule containing at least one probiotics strain selected from the group, it is possible to provide a health functional food soft capsule that remains in the stomach and exposes the contents in the small intestine.

또한, 본 발명에 의하면, 하이프로멜로스(hypromellose) 또는 하이드록시프로필 메틸셀룰로스(hydroxypropyl methylcellulose, HPMC)를 사용하여 코팅한 장용형 연질캡슐형 건강기능식품으로서 신뢰성과 효능을 효과적으로 확보할 수 있는 장점이 있다.In addition, according to the present invention, as an enteric soft capsule-type health functional food coated with hypromellose or hydroxypropyl methylcellulose (HPMC), it has the advantage of effectively securing reliability and efficacy. there is.

도 1은 본 발명의 일 실시예에 따른 연질캡슐형 건강기능식품의 제조방법에 대한 흐름도이다.1 is a flowchart of a method for manufacturing a soft capsule type health functional food according to an embodiment of the present invention.

본 발명은 다양한 변형을 가할 수 있고 여러 가지 실시 예를 가질 수 있는 바, 특정 실시 예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.Since the present invention can apply various modifications and have various embodiments, specific embodiments will be illustrated in the drawings and described in detail in the detailed description. However, this is not intended to limit the present invention to specific embodiments, and should be understood to include all conversions, equivalents, or substitutes included in the spirit and scope of the present invention. In describing the present invention, if it is determined that a detailed description of related known technologies may obscure the gist of the present invention, the detailed description will be omitted.

이하, 첨부된 도면을 참조하여 본 발명의 바람직한 실시예들을 상세하게 설명하면 다음과 같다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.

도 1은 본 발명의 일 실시예에 따른 연질캡슐형 건강기능식품의 제조방법에 대한 흐름도이다.1 is a flowchart of a method for manufacturing a soft capsule type health functional food according to an embodiment of the present invention.

도 1을 참조하면, 연질캡슐형 건강기능식품의 제조방법은, 측량된 건강기능식품의 원료를 상대습도 65% 이하, 온도 20℃ 내지 24℃의 분위기에서 30분 내지 50분간 배합하고(S11), 배합한 원료가 충진된 연질캡슐을 생성하고(S12), 그리고 연질캡슐 상에 액상의 코팅 물질을 분무하여 코팅층을 형성하는(S13) 일련의 공정들을 포함한다. 코팅 물질은 지방, 지방산, 왁스, 쉘락, 초산프탈산셀룰로오스, 프탈산히드록시메틸셀룰로오스(hydroxypropyl methylcellulose, HPMC)로 이루어진 그룹에서 선택되는 어느 하나 이상을 포함한다.Referring to Figure 1, the manufacturing method of the soft capsule type health functional food, the raw material of the measured health functional food is blended for 30 minutes to 50 minutes in an atmosphere of 20 ℃ to 24 ℃ relative humidity of 65% or less (S11) , It includes a series of steps of creating a soft capsule filled with the blended raw materials (S12), and forming a coating layer by spraying a liquid coating material on the soft capsule (S13). The coating material includes at least one selected from the group consisting of fat, fatty acid, wax, shellac, cellulose phthalate acetate, and hydroxymethyl cellulose phthalate (HPMC).

원료는 락토바실러스(lactobacillus), 락토코커스, 엔테로코커스(enterococcus), 스트렙토코커스(streptococcus) 및 비피도박테리움(bifidobacterium)로 이루어진 그룹에서 선택되는 어느 하나 이상의 프로바이오틱스 균주를 포함한다.The raw material includes one or more probiotic strains selected from the group consisting of lactobacillus, lactococcus, enterococcus, streptococcus and bifidobacterium.

즉, 본 실시예에서는 상술한 프로바이오틱스 균주로 이루어진 미생물 또는 이를 혼합한 균과 균 또는 배양체를 배양시키기 위한 배지 및 보호제를 원료로 사용할 수 있다.That is, in the present embodiment, a microorganism consisting of the above-described probiotics strain or a mixture thereof and a culture medium and a protective agent for culturing the bacteria or culture body may be used as raw materials.

가령 프로바이오틱스는 적정량을 섭취했을 때 숙주의 건강에 도움이 되는 살아있는 미생물로 정의되며, 독성이 없이 비교적 안전하다. 프로바이오틱스 유산균은 만성 위염의 원인균인 헬리코박터를 사멸하거나 억제하는 효과도 뛰어나다. 또한 락토라실러스 플랜타럼 HY7714는 자외선에 의한 피부 손상과 피부 보습과 관련해 인정을 받았다.For example, probiotics are defined as living microorganisms that, when ingested in adequate amounts, confer health benefits to the host, and are relatively safe and non-toxic. Probiotics lactic acid bacteria are also excellent in killing or suppressing Helicobacter, the cause of chronic gastritis. In addition, Lactoracillus Plantarum HY7714 was recognized for skin damage caused by ultraviolet rays and skin moisturizing.

또한, 락토라실러스는 과채유래 유산규인 락토바실러스 플랜타럼 CJLP133(L.plantarum CJLP133)을 포함하며, 이는 락토바실러스 속, 플랜타럼 종의 CJLP133이라는 이름의 균을 뜻한다. 프로바이오틱스는 균주에 따라 콜레스트롤 수치 개선, 면역 질환 개선, 장 질환 및 변비나 설사 개선, 아토피 질환 개선, 유당 불내증 개선 등의 효능을 가진다.In addition, Lactobacillus includes Lactobacillus plantarum CJLP133 (L.plantarum CJLP133), a lactobacillus derived from fruits and vegetables, which means a bacterium named CJLP133 of the genus Lactobacillus and Plantarum species. Depending on the strain, probiotics have effects such as improving cholesterol levels, improving immune diseases, improving intestinal diseases and constipation or diarrhea, improving atopic diseases, and improving lactose intolerance.

실시예 1Example 1

프로바이오틱스 균주가 충진된 연질캡슐의 피막은 젤라틴 40%, 글리세린 40%, 정제수 20%로 구성된 것을 사용하였다. 코팅제로는 장용성 기제인 히드록시메틸셀룰로오스(HPMC)를 사용하고, 필름 코팅의 유연성을 높이기 위한 가소제로는 AMG(acethylated monoglyceride)를 사용하였다. 그리고 코팅용매로는 발효주정(95%)과 정제수를 혼합하여 사용하였다.The shell of the soft capsule filled with probiotics strains was composed of 40% gelatin, 40% glycerin, and 20% purified water. Hydroxymethylcellulose (HPMC), an enteric base, was used as a coating agent, and acetylated monoglyceride (AMG) was used as a plasticizer to increase the flexibility of the film coating. And as a coating solvent, a mixture of fermented alcohol (95%) and purified water was used.

코팅액은 총 중량 500g으로 제조하고, 그 중 고형분이 HPMC의 사용량을 전체 용액의 중량대비 6%, 8%, 10%로 각각 변화시켜 코팅층을 형성하였다. 용매로는 발효주정과 정제수를 85:15 중량비로 혼합한 것을 사용하였다.The coating solution was prepared with a total weight of 500 g, and the coating layer was formed by changing the amount of HPMC used in the solid content to 6%, 8%, and 10%, respectively, based on the weight of the total solution. As a solvent, a mixture of fermented alcohol and purified water at a weight ratio of 85:15 was used.

코팅액의 제조는 발효주정과 정제수 혼합 용매를 균질기(homogenizer)로 교반하면서 HPMC와 AMG를 투입하여 2500rpm에서 한 시간 정도 더 교반하여 균질한 코팅액을 제조하였다.To prepare the coating solution, while stirring the mixed solvent of fermented alcohol and purified water with a homogenizer, HPMC and AMG were added and further stirred at 2500 rpm for about an hour to prepare a homogeneous coating solution.

그리고 준비된 코팅액을 연질캡슐에 분무하여 연질캡슐 상에 코팅층을 형성하였다. 코팅층을 위한 코팅액은 500㎎ 용량의 연질캡슐 당 2㎎이 사용되었다.Then, the prepared coating solution was sprayed onto the soft capsules to form a coating layer on the soft capsules. 2 mg of the coating solution for the coating layer was used per soft capsule of 500 mg capacity.

코팅층의 HPMC 농도, 흡기 온도, 코팅분사 액량이 연질캡슐의 코팅 표면에 미치는 영향을 알아보기 위하여 필름 코팅기(Hi-coater, Freund Corporate)를 사용하였다. HPMC 농도 6, 8, 10%로 각각에 대하여 흡기 온도는 32, 35, 38℃로 각각 조절하고, 코팅분사 액량은 펌프로 7.5, 11.25, 15.0g/min으로 각각 조절하여 코팅층의 품질을 평가하였다.A film coater (Hi-coater, Freund Corporate) was used to examine the effect of the HPMC concentration of the coating layer, the intake air temperature, and the amount of coating injection liquid on the coating surface of the soft capsule. The quality of the coating layer was evaluated by adjusting the intake air temperature to 32, 35, and 38 ℃, respectively, and the coating spraying liquid amount to 7.5, 11.25, and 15.0 g / min with a pump, respectively, for HPMC concentrations of 6, 8, and 10%. .

코팅층의 균일한 상태를 확인하기 위해 이온 스퍼터 코팅기(ion suptter coater)로 금이온(gold-ion)을 코팅한 다음 단면을 주사전자현미경을 이용하여 100배율에서 관찰하였다. 그 결과, 코팅액의 분사 액량이 코팅 품질을 저하시키는 백색현상을 일으키는데 상당한 영향을 주고 있음을 확인하였다.In order to confirm the uniform state of the coating layer, gold-ion was coated with an ion sputter coater, and then the cross section was observed at 100 magnification using a scanning electron microscope. As a result, it was confirmed that the spray liquid amount of the coating liquid has a significant effect on causing the white phenomenon that deteriorates the coating quality.

붕해시험은 건강기능식품공전에 기술되어 있는 붕해시험법으로 측정하였다. 즉, 제조된 연질캡슐을 인공위액과 인공장액에 6개씩 넣은 다음, 인공위액은 120분, 인공장액은 60분간 상하운동을 한 다음 관찰하여 연질캡슐의 용해를 관찰하였다. 사용한 인공위액은 염화나트륨 2.0g에 염산 7.0㎖과 물을 넣어 녹여 1L로 제조하였고(pH 1.2), 인공장액은 0.2mol/L 인산이수소칼륨시액 250㎖에 0.2mol/L과 물을 넣어 1L로 제조하였다(pH 6.8).The disintegration test was measured by the disintegration test method described in the Health Functional Food Codex. That is, the prepared soft capsules were put into artificial gastric juice and artificial intestinal fluid, 6 each, and then the artificial gastric fluid was moved up and down for 120 minutes and the artificial intestinal fluid was moved up and down for 60 minutes, and then the dissolution of the soft capsule was observed. The used artificial gastric juice was prepared by dissolving 7.0 ml of hydrochloric acid and water in 2.0 g of sodium chloride to make 1 L (pH 1.2). prepared (pH 6.8).

실험 결과, 백색현상이 발생하는 것을 방지하기 위해 즉, 연질캡슐의 표면 코팅 시 표면의 투명도를 증가시키기 위해, 발효주정과 정제수 혼합 용매를 균질기(homogenizer)로 교반하면서 HPMC와 AMG를 투입하여 2500rpm에서 한 시간 정도 더 교반하여 균질한 코팅액을 제조한 후, 코팅액 분사량 7.5~15.0g/min, 흡기 온도 실온(28℃) 내지 40℃(바람직하게는 32~38℃), HPMC 농도 6~10%(바람직하게는 6~8%)의 코팅 조건에서 코팅액을 분무하여 연질캡슐의 표면에 부착시키면서 분사되는 즉시 가루형태로 건조되어 연질캡슐 표면에 부착되도록 에어 스프레이(air spray)를 사용하는 공정에서, 코팅액이 분사될 때까지 혹은 연질캡슐 표면에 부착될 때까지 연질캡슐 표면에 균일한 코팅액이 균일하게 붙어 건조되도록 하는 것이 중요한 것으로 확인되었다.As a result of the experiment, in order to prevent the white phenomenon from occurring, that is, to increase the transparency of the surface when coating the surface of the soft capsule, while stirring the mixed solvent of fermented alcohol and purified water with a homogenizer, HPMC and AMG were added at 2500 rpm After stirring for an additional hour to prepare a homogeneous coating liquid, the coating liquid spray amount is 7.5 ~ 15.0 g / min, the intake temperature is room temperature (28 ℃) to 40 ℃ (preferably 32 ~ 38 ℃), HPMC concentration 6 ~ 10% In the process of using air spray to spray the coating liquid under coating conditions of (preferably 6-8%) and attach it to the surface of the soft capsule, dry it in powder form as soon as it is sprayed and attach it to the surface of the soft capsule, It was confirmed that it is important to ensure that a uniform coating solution is uniformly attached to the surface of the soft capsule and dried until the coating solution is sprayed or adhered to the surface of the soft capsule.

상기에서는 본 발명의 바람직한 실시예를 참조하여 설명하였지만, 해당 기술 분야의 숙련된 당업자는 청구범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다.Although the above has been described with reference to preferred embodiments of the present invention, those skilled in the art can variously modify and change the present invention without departing from the spirit and scope of the present invention described in the claims. You will understand.

Claims (1)

연질캡슐형 건강기능식품의 제조방법으로서,
측량된 건강기능식품의 원료를 상대습도 65% 이하, 온도 20℃ 내지 24℃의 분위기에서 30분 내지 50분간 배합하는 단계;
배합한 원료가 충진된 연질캡슐을 생성하는 단계; 및
상기 연질캡슐 상에 액상의 코팅 물질을 분무하여 코팅층을 형성하는 단계를 포함하고,
상기 코팅 물질은 프탈산히드록시메틸셀룰로오스(Hydroxypropyl methylcellulose phthalate, 이하 HPMC)를 포함하고, 상기 코팅하는 단계에서, 상기 액상의 코팅 물질의 전체 중량 대비 6~8 중량%의 HPMC, 코팅액 분사량 7.5~15.0g/min 및 흡기 온도 32℃ 내지 38℃의 코팅 조건에서 상기 코팅 물질을 함유한 코팅액을 분무하여 상기 연질캡슐의 표면에 부착시키면서 분사되는 즉시 연질캡슐 표면에 부착되어 가루형태로 건조되도록 에어 스프레이를 사용하는 공정에서, 상기 코팅액이 분사될 때까지 그리고 상기 연질캡슐 표면에 부착될 때까지 상기 연질캡슐 표면에 균일한 코팅액이 균일하게 붙어 건조되도록 코팅 환경을 유지하며,
상기 코팅액은, 발효주정과 정제수를 85:15 중량비로 혼합한 용매를 균질기(homogenizer)로 교반한 후, HPMC와 AMG(acethylated monoglyceride)를 투입하고 2500rpm에서 한 시간을 더 교반하여 제조하고,
상기 코팅액은 500mg 용량의 상기 연질캡슐 당 2mg을 사용하며,
상기 원료는 락토바실러스(lactobacillus), 락토코커스, 엔테로코커스(enterococcus), 스트렙토코커스(streptococcus) 및 비피도박테리움(bifidobacterium)로 이루어진 그룹에서 선택되는 어느 하나 이상의 프로바이오틱스 균주를 포함하는
건강기능식품의 제조방법.
As a method for producing a soft capsule type health functional food,
Blending the raw material of the measured health functional food in an atmosphere with a relative humidity of 65% or less and a temperature of 20 ° C to 24 ° C for 30 minutes to 50 minutes;
Generating a soft capsule filled with the blended raw materials; and
Forming a coating layer by spraying a liquid coating material on the soft capsule,
The coating material includes hydroxypropyl methylcellulose phthalate (hereinafter referred to as HPMC), and in the coating step, 6 to 8% by weight of HPMC based on the total weight of the liquid coating material, the amount of spraying the coating liquid is 7.5 to 15.0 g. /min and air intake temperature of 32 ° C to 38 ° C, the coating liquid containing the coating material is sprayed and adhered to the surface of the soft capsule, and air spray is used so that it is attached to the surface of the soft capsule immediately after being sprayed and dried in the form of powder. In the process of maintaining the coating environment so that the coating liquid is uniformly adhered to the surface of the soft capsule and dried until the coating liquid is sprayed and adhered to the surface of the soft capsule,
The coating solution was prepared by stirring a solvent in which fermented alcohol and purified water were mixed at a weight ratio of 85:15 with a homogenizer, then adding HPMC and acetylated monoglyceride (AMG) and stirring at 2500 rpm for an additional hour,
2mg of the coating solution is used per soft capsule of 500mg capacity,
The raw material includes any one or more probiotic strains selected from the group consisting of lactobacillus, lactococcus, enterococcus, streptococcus and bifidobacterium
Manufacturing method of health functional food.
KR1020200136941A 2020-04-06 2020-10-21 Method for producing soft capsule type functional health food KR102483912B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200136941A KR102483912B1 (en) 2020-04-06 2020-10-21 Method for producing soft capsule type functional health food

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200041403 2020-04-06
KR1020200136941A KR102483912B1 (en) 2020-04-06 2020-10-21 Method for producing soft capsule type functional health food

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020200041403 Division 2020-04-06 2020-04-06

Publications (2)

Publication Number Publication Date
KR20210123989A KR20210123989A (en) 2021-10-14
KR102483912B1 true KR102483912B1 (en) 2023-01-04

Family

ID=78151446

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200136941A KR102483912B1 (en) 2020-04-06 2020-10-21 Method for producing soft capsule type functional health food

Country Status (1)

Country Link
KR (1) KR102483912B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102420168B1 (en) 2021-12-02 2022-07-13 체르엠(주) Dietary health functional food composition and manufacturing method thereof
KR102464572B1 (en) 2022-03-22 2022-11-10 대한켐텍 주식회사 Capsule of probiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020063978A (en) * 2001-01-31 2002-08-07 전홍렬 Lactic acid bacteria-containing microgranular composition for enteric delivery and process for the preparation thereof
KR100605235B1 (en) * 2004-03-17 2006-07-28 한국유나이티드제약 주식회사 Hard capsule formulation containing Pantoprazole and method for producing the same
KR101378974B1 (en) * 2011-12-19 2014-03-31 한미약품 주식회사 Enteric capsule formulation containing high-concentrated lactobacillus strain and method for the preparation thereof
KR20150074252A (en) * 2013-12-23 2015-07-02 고려은단주식회사 Vitamin C, Hyroxypropyl-methyle-cellulose mixed powder method of manufacturing using direct compression tableting process to produce Vitamin C tablet
KR101915904B1 (en) 2016-08-12 2018-11-06 한국식품연구원 Composition for preventing or treating of climacterium comprising Lactobacillus intestinalis

Also Published As

Publication number Publication date
KR20210123989A (en) 2021-10-14

Similar Documents

Publication Publication Date Title
JP5070043B2 (en) Oral dosage form containing probiotic bacteria
US7122370B2 (en) Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
JP5392672B2 (en) Novel lactobacilli strains and uses thereof
US8697126B2 (en) Compositions for enternal application of microorganisms
CN109451727A (en) The composition and its preparation and application of probiotics and digestive ferment
RU2526199C2 (en) Composition facilitating collagen production
KR102483912B1 (en) Method for producing soft capsule type functional health food
TWI584824B (en) A capsule for delivery to a large intestine and a method of manufacturing the same
Das et al. Microencapsulation of probiotic bacteria and its potential application in food technology
TW200938214A (en) Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same
CA2324364A1 (en) Starch capsules containing microorganisms and/or polypeptides or proteins and a process for producing them
KR101378974B1 (en) Enteric capsule formulation containing high-concentrated lactobacillus strain and method for the preparation thereof
Harel et al. Protection and delivery of probiotics for use in foods
JP2968089B2 (en) Coating material and enteric-coated granules using the same
CN107028985A (en) Application of the heavy wall mushroom probiotics in preventing and/or treating diabetes and its relevant disease
JP6457963B2 (en) Large intestine delivery capsule formulation
JP5957280B2 (en) Large intestine delivery seamless capsule preparation and method for producing the same
US20210186887A1 (en) Moisture resistant probiotic granule and methods of producing the same
JP3187502B2 (en) Enteric granules
JPH05186337A (en) Enteric granule composed of multiple granules
KR102163637B1 (en) Method for producing functional health food
JP2003012526A (en) Pharmaceutical preparation including useful live bacterium
JP2004250338A (en) Useful live bacterium pharmaceutical preparation
KR102167931B1 (en) Method for producing functional health food
KR20180070484A (en) lactic acid bacteria improved stability and preparing method thereof

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E902 Notification of reason for refusal
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right